Managing Partner

Antoine Papiernik is a Managing Partner at Sofinnova Partners. He joined Sofinnova Partners in 1997, and was previously with CDC-Innovation, the venture arm of  the Caisse des Dépôts group. Since joining Sofinnova Partners, Antoine has been an initial investor and active board member in public companies like Actelion, Addex, Orexo, NovusPharma, Movetis and Stentys, which went public respectively on the Zürich stock exchange, the Stockholm stock exchange, the Milan Nuovo Mercato, the Belgium Stock Exchange and EuroNext Paris, in Cotherix (initially NASDAQ listed, then sold to Actelion), CoreValve (sold to Medtronic) and Fovea (sold to Sanofi Aventis). He has also invested in and is a board member of private companies CoAxia, EOS, Mainstay and Recor. Antoine has an MBA from the Wharton School of Business, University of Pennsylvania.